Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ATB1651 / AmtixBio
NCT06327295: A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis	Not yet recruiting	2	120	RoW	ATB1651-102- Cohort 1, ATB1651-102- Cohort 2, ATB1651-102- Cohort 3, ATB1651-102- Cohort 4, Placebo	AmtixBio Co., Ltd.	Onychomycosis	06/25	01/26
NCT05089409: A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis	Completed	1	30	RoW	ATB1651, 2 mg/mL, ATB1651, 5 mg/mL, ATB1651, 10 mg/mL, ATB1651, 20 mg/mL, ATB1651, 30 mg/mL, Placebo	AmtixBio Co., Ltd., Novotech (Australia) Pty Limited	Onychomycosis	06/23	09/23